Style | Citing Format |
---|---|
MLA | Daneshjou D, et al.. "Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome." Trends in Endocrinology and Metabolism, vol. 31, no. 12, 2020, pp. 890-892. |
APA | Daneshjou D, Soleimani Mehranjani M, Zadeh Modarres S, Shariatzadeh MA (2020). Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome. Trends in Endocrinology and Metabolism, 31(12), 890-892. |
Chicago | Daneshjou D, Soleimani Mehranjani M, Zadeh Modarres S, Shariatzadeh MA. "Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome." Trends in Endocrinology and Metabolism 31, no. 12 (2020): 890-892. |
Harvard | Daneshjou D et al. (2020) 'Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome', Trends in Endocrinology and Metabolism, 31(12), pp. 890-892. |
Vancouver | Daneshjou D, Soleimani Mehranjani M, Zadeh Modarres S, Shariatzadeh MA. Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome. Trends in Endocrinology and Metabolism. 2020;31(12):890-892. |
BibTex | @article{ author = {Daneshjou D and Soleimani Mehranjani M and Zadeh Modarres S and Shariatzadeh MA}, title = {Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome}, journal = {Trends in Endocrinology and Metabolism}, volume = {31}, number = {12}, pages = {890-892}, year = {2020} } |
RIS | TY - JOUR AU - Daneshjou D AU - Soleimani Mehranjani M AU - Zadeh Modarres S AU - Shariatzadeh MA TI - Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome JO - Trends in Endocrinology and Metabolism VL - 31 IS - 12 SP - 890 EP - 892 PY - 2020 ER - |